Could interferon-gamma be a therapeutic Target for treating heart failure?

Heart Failure Reviews

Volumn 19, Issue 2, 2014, Pages 227-236

  Levick, Scott P ^a   Goldspink, Paul H ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Fibrosis; Heart failure; Hypertrophy; Inflammation; Interferon gamma

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BETA1A INTERFERON; GAMMA INTERFERON; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; RECOMBINANT ALPHA INTERFERON; STAT PROTEIN; SYNTENIN;

ADENOVIRUS INFECTION; ARTICLE; COXSACKIE VIRUS INFECTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG TARGETING; ENTEROVIRUS INFECTION; FIBROBLAST; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE NECROSIS; HEART PROTECTION; HEART VENTRICLE REMODELING; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; HEART FAILURE; HUMANS; INTERFERON-GAMMA; MYOCYTES, CARDIAC; MYOFIBROBLASTS; SIGNAL TRANSDUCTION;

EID: 84896734384     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-013-9393-8     Document Type: Article

References (68)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236-241
2. Oikonomou E, Tousoulis D, Siasos G, Zaromitidou M, Papavassiliou AG, Stefanadis C (2011) The role of inflammation in heart failure: new therapeutic approaches. Hellenic J Cardiol 52:30-40
3. Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N (2010) Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15:543-562
4. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133-3140
5. Mann DL, McMurray JJ, Packer M, Swedberg K, Borer JS, Colucci WS et al (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL). Circulation 109:1594-1602
6. Hinglais N, Huedes D, Nicoletti A, Manset C, Laurent M, Bariety J et al (1994) Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab Invest 70:286-294
7. Kanzaki Y, Terasaki F, Okabe M, Hayashi T, Toko H, Shimomura H et al (2001) Myocardial inflammatory cell infiltrates in cases of dilated cardiomyopathy as a determinant of outcome following partial left ventriculectomy. Jpn Circ J 65:797-802
8. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S et al (2002) Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: a possible role for left ventricular remodeling. J Am Coll Cardiol 39:241-246
9. Frangogiannis NG (2012) Regulation of the inflammatory response in cardiac repair. Circ Res 110:159-173
10. Bujak M, Dobaczewski M, Chatila K, Mendoza LH, Li N, Reddy A et al (2008) Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling. Am J Pathol 173:57-67
11. Hayashidani S, Tsutsui H, Shiomi T, Ikeuchi M, Matsusaka H, Suematsu N et al (2003) Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 108:2134-2140
12. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K et al (2004) Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation? Hypertension 43:739-745
13. Guedes PM, Veloso VM, Afonso LC, Caliari MV, Carneiro CM, Diniz LF et al (2009) Development of chronic cardiomyopathy in canine chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase. Vet Immunol Immunopathol 130:43-52
14. Cheng X, Ding Y, Xia C, Tang T, Yu X, Xie J et al (2009) Atorvastatin modulates Th1/Th2 response in patients with chronic heart failure. J Card Fail 15:158-162
15. Levick SP, McLarty JL, Murray DB, Freeman RM, Carver WE, Brower GL (2009) Cardiac mast cells mediate left ventricular fibrosis in the hypertensive rat heart. Hypertension 53:1041-1047
16. Han YL, Li YL, Jia LX, Cheng JZ, Qi YF, Zhang HJ et al (2012) Reciprocal interaction between macrophages and T cells stimulates IFN-gamma and MCP-1 production in Ang II-induced cardiac inflammation and fibrosis. PLoS ONE 7:e35506
17. Yu Q, Watson RR, Marchalonis JJ, Larson DF (2005) A role for T lymphocytes in mediating cardiac diastolic function. Am J Physiol Heart Circ Physiol 289:H643-H651
18. Reifenberg K, Lehr HA, Torzewski M, Steige G, Wiese E, Kupper I et al (2007) Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am J Pathol 171:463-472
19. Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N et al (2012) Interferon-gamma ablation exacerbates myocardial hypertrophy in diastolic heart failure. Am J Physiol Heart Circ Physiol 303:H587-H596
20. Peng H, Yang XP, Carretero OA, Nakagawa P, D'Ambrosio M, Leung P et al (2011) Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6 J mice. Exp Physiol 96:756-764
21. Yu Q, Horak K, Larson DF (2006) Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension 48:98-104
22. Jin H, Li W, Yang R, Ogasawara A, Lu H, Paoni NF (2005) Inhibitory effects of interferon-gamma on myocardial hypertrophy. Cytokine 31:405-414
23. Borda E, Leiros CP, Sterin-Borda L, de Bracco MM (1991) Cholinergic response of isolated rat atria to recombinant rat interferon-gamma. J Neuroimmunol 32:53-59
24. Machado FS, Souto JT, Rossi MA, Esper L, Tanowitz HB, Aliberti J et al (2008) Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 10:1558-1566
25. Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L, Higuchi ML et al (2005) Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in chagas' disease cardiomyopathy. Am J Pathol 167:305-313
26. Patten M, Kramer E, Bunemann J, Wenck C, Thoenes M, Wieland T et al (2001) Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo. Pflugers Arch 442:920-927
27. Cosper PF, Harvey PA, Leinwand LA (2012) Interferon-gamma causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis. Am J Pathol 181:2038-2046
28. Hellkvist J, Tufveson G, Gerdin B, Johnsson C (2002) Characterization of fibroblasts from rejecting tissue: the hyaluronan production is increased. Transplantation 74:1672-1677
29. Wang Z, Jiang B, Brecher P (2002) Selective inhibition of STAT3 phosphorylation by sodium salicylate in cardiac fibroblasts. Biochem Pharmacol 63:1197-1207
30. Schroder K, Hertzog PJ, Ravasi T, Hume DA (2004) Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75:163-189
31. Ramana CV, Gil MP, Schreiber RD, Stark GR (2002) Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 23:96-101
32. Kurdi M, Booz GW (2009) JAK redux: a second look at the regulation and role of JAKs in the heart. Am J Physiol Heart Circ Physiol 297:H1545-H1556
33. Booz GW, Day JN, Baker KM (2002) Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure. J Mol Cell Cardiol 34:1443-1453
34. Rohini A, Agrawal N, Koyani CN, Singh R (2010) Molecular targets and regulators of cardiac hypertrophy. Pharmacol Res 61:269-280
35. Gough DJ, Sabapathy K, Ko EY, Arthur HA, Schreiber RD, Trapani JA et al (2007) A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes. J Biol Chem 282:938-946
36. McLarty JL, Melendez GC, Brower GL, Janicki JS, Levick SP (2011) Tryptase/protease-activated receptor 2 interactions induce selective mitogen-activated protein kinase signaling and collagen synthesis by cardiac fibroblasts. Hypertension 58:264-270
37. Kehat I, Molkentin JD (2010) Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy. Ann N Y Acad Sci 1188:96-102
38. Lin JJ, Jiang H, Fisher PB (1998) Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene 207:105-110
39. Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L et al (2005) mda-9/Syntenin: a positive regulator of melanoma metastasis. Cancer Res 65:10901-10911
40. Sarkar D, Boukerche H, Su ZZ, Fisher PB (2008) mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis. Cancer Res 68:3087-3093
41. Boukerche H, Aissaoui H, Prevost C, Hirbec H, Das SK, Su ZZ et al (2010) Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB. Oncogene 29:3054-3066
42. Steinberg SF (2012) Cardiac actions of protein kinase C isoforms. Physiology (Bethesda) 27:130-139
43. Seo JY, Kim DY, Lee YS, Ro JY (2009) Cytokine production through PKC/p38 signaling pathways, not through JAK/STAT1 pathway, in mast cells stimulated with IFNgamma. Cytokine 46:51-60
44. Deb DK, Sassano A, Lekmine F, Majchrzak B, Verma A, Kambhampati S et al (2003) Activation of protein kinase C delta by IFN-gamma. J Immunol 171:267-273
45. Choudhury GG (2004) A linear signal transduction pathway involving phosphatidylinositol 3-kinase, protein kinase Cepsilon, and MAPK in mesangial cells regulates interferon-gamma-induced STAT1alpha transcriptional activation. J Biol Chem 279:27399-27409
46. Venkatesan BA, Mahimainathan L, Ghosh-Choudhury N, Gorin Y, Bhandari B, Valente AJ et al (2006) PI 3 kinase-dependent Akt kinase and PKCepsilon independently regulate interferon-gamma-induced STAT1alpha serine phosphorylation to induce monocyte chemotactic protein-1 expression. Cell Signal 18:508-518
47. Mazzi P, Donini M, Margotto D, Wientjes F, Dusi S (2004) IFN-gamma induces gp91phox expression in human monocytes via protein kinase C-dependent phosphorylation of PU.1. J Immunol 172:4941-4947
48. Hardy PO, Diallo TO, Matte C, Descoteaux A (2009) Roles of phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase in the regulation of protein kinase C-alpha activation in interferon-gamma-stimulated macrophages. Immunology 128:e652-e660
49. Ivaska J, Bosca L, Parker PJ (2003) PKCepsilon is a permissive link in integrin-dependent IFN-gamma signalling that facilitates JAK phosphorylation of STAT1. Nat Cell Biol 5:363-369
50. Palaniyandi SS, Sun L, Ferreira JC, Mochly-Rosen D (2009) Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res 82:229-239
51. Barnholt KE, Kota RS, Aung HH, Rutledge JC (2009) Adenosine blocks IFN-gamma-induced phosphorylation of STAT1 on serine 727 to reduce macrophage activation. J Immunol 183:6767-6777
52. Sikorski K, Czerwoniec A, Bujnicki JM, Wesoly J, Bluyssen HA (2011) STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNgamma, TLR4 and IL-6 in vascular disease. Cytokine Growth Factor Rev 22:211-219
53. Li N, Salter RC, Ramji DP (2011) Molecular mechanisms underlying the inhibition of IFN-gamma-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs. J Cell Biochem 112:675-683
54. Stephanou A (2002) Activated STAT-1 pathway in the myocardium as a novel therapeutic target in ischaemia/reperfusion injury. Eur Cytokine Netw 13:401-403
55. Rocha Rodrigues DB, dos Reis MA, Romano A, Pereira SA, Teixeira VP, Tostes S Jr. et al (2012) In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure. Clin Dev Immunol 2012:361730
56. Forster O, Hilfiker-Kleiner D, Ansari AA, Sundstrom JB, Libhaber E, Tshani W et al (2008) Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur J Heart Fail 10:861-868
57. Lio D, Scola L, Crivello A, Bonafe M, Franceschi C, Olivieri F et al (2002) Allele frequencies of +874T-> A single nucleotide polymorphism at the first intron of interferon-gamma gene in a group of Italian centenarians. Exp Gerontol 37:315-319
58. Chong WP, Ip WK, Tso GH, Ng MW, Wong WH, Law HK et al (2006) The interferon gamma gene polymorphism +874A/T is associated with severe acute respiratory syndrome. BMC Infect Dis 6:82
59. Vallinoto AC, Graca ES, Araujo MS, Azevedo VN, Cayres-Vallinoto I, Machado LF et al (2010) IFNG +874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis. Hum Immunol 71:692-696
60. Lutton CW, Gauntt CJ (1985) Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice. J Interferon Res 5:137-146
61. + T-cell infiltration during autoimmune myocarditis. Immunol Cell Biol 82:119-126
62. Deonarain R, Cerullo D, Fuse K, Liu PP, Fish EN (2004) Protective role for interferon-beta in coxsackievirus B3 infection. Circulation 110:3540-3543
63. Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M et al (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793-2798
64. Schultheiss HP, Kuhl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32:2616-2625
65. Matsumori A, Tomioka N, Kawai C (1988) Protective effect of recombinant alpha interferon on coxsackievirus B3 myocarditis in mice. Am Heart J 115:1229-1232
66. Daliento L, Calabrese F, Tona F, Caforio AL, Tarsia G, Angelini A et al (2003) Successful treatment of enterovirus-induced myocarditis with interferon-alpha. J Heart Lung Transplant 22:214-217
67. Yamamoto N, Shibamori M, Ogura M, Seko Y, Kikuchi M (1998) Effects of intranasal administration of recombinant murine interferon-gamma on murine acute myocarditis caused by encephalomyocarditis virus. Circulation 97:1017-1023
68. Horwitz MS, La Cava A, Fine C, Rodriguez E, Ilic A, Sarvetnick N (2000) Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 6:693-697